Activating Innate Immunity by a STING Signal Amplifier for Local and Systemic Immunotherapy.

Song, Wen; Song, Shu-Jun; Kuang, Jing; Yang, Hang; Yu, Tao; Yang, Fan; Wan, Tao; Xu, Yi et al. · ACS Nano · 2022

basic_science · Level V

Where this comes from

Abstract

The number of patients who benefit from acquired immunotherapy is limited. Stimulator of interferon genes (STING) signal activation is a significant component to enhance innate immunity, which has been used to realize broad-spectrum immunotherapy. Here, M@P@HA nanoparticles, as a STING signal amplifier, are constructed to enhance innate immunotherapy. Briefly, when M@P@HA was targeted into tumor cells, the nanoparticles decomposed with Mn<sup>2+</sup> and activated the release of protoporphyrin (PpIX). Under light irradiation, the generated reactive oxygen species disrupt the cellular redox homeostasis to lead cytoplasm leakage of damaged mitochondrial double-stranded (ds) DNA, which is the initiator of the STING signal. Simultaneously, Mn<sup>2+</sup> as the immunoregulator could significantly increase the activity of related protein of a STING signal, such as cyclic GMP-AMP synthase (cGAS) and STING, to further amplify the STING signal of tumor cells. Subsequently, the STING signal of tumor-associated macrophages (TAM) is also activated by capturing dsDNA and Mn<sup>2+</sup> that escaped from tumor cells, so as to enhance innate immunity. It is found that, by amplifying the STING signal of tumor tissue, M@P@HA could not only activate innate immunity but also cascade to activate CD8<sup>+</sup> T cell infiltration even in a tumor with low immunogenicity.

Medical subject headings